Ładuje się......
Inhaled corticosteroids with combination inhaled long‐acting beta(2)‐agonists and long‐acting muscarinic antagonists for chronic obstructive pulmonary disease
BACKGROUND: Management of chronic obstructive pulmonary disease (COPD) commonly involves long‐acting bronchodilators including beta‐agonists (LABA) and muscarinic antagonists (LAMA). In individuals with persistent symptoms or frequent exacerbations, inhaled corticosteroids (ICS) are also used. LABA...
Zapisane w:
| Wydane w: | Cochrane Database Syst Rev |
|---|---|
| Główni autorzy: | , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
John Wiley & Sons, Ltd
2016
|
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6464947/ https://ncbi.nlm.nih.gov/pubmed/27830584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011600.pub2 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|